Last week, we presented our inaugural Education Excellence Award to Dr. Jihad Mustapha at a CSI event in connection with the Amputation Prevention Symposia held in Chicago. Dr. Mustapha has been a pioneer in preventing amputations due to critical limb ischemia (CLI) which is the worst form of peripheral arterial disease (PAD). We are honored that Dr. Mustapha worked with CSI last year to inspire and train 188 physicians as part of our industry-leading professional education program on the treatment of CLI. Here is a photo of Dr. Mustapha celebrating the award with our CEO, Scott Ward, and a panel of esteemed key opinion leaders in the field of amputation prevention at our most recent educational event.
For more information about product availability globally, please click below.
→APAC (Asia-Pacific)
→EMEA (Europe, Middle East, Africa)
In July 2018, Cardiovascular Systems, Inc. (CSI®) announced that OrbusNeich Medical Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems outside the United States and Japan.
In November 2016, Cardiovascular Systems, Inc. (CSI®) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.
Now Introducing
Designed to perform
Flexible nitinol body for reduced wire bias and kink resistance during coronary procedures
Designed for trackability
Stainless steel support coil provides floppy, shapeable tip for navigation in multi-vessel coronary lesions
At CSI, weare a culture of innovation.
We observe carefully, listen closely and collaborate extensively,
seeking opportunities to help interventionalists do their jobs more easily and more effectively –
all with the goal of improving patient care.